Musculoskeletal System
Topics
- Arthritis
- Cachexia
- Childhood Leukemia
- Congenital Muscular Dystrophy
- Facioscapulohumeral Muscular Dystrophy
- Lymphoma
- Myasthenia Gravis
- Myotonic Dystrophy
- Osteoarthritis
- Osteogenesis Imperfecta
- Osteoporosis
- Rheumatoid Arthritis
- Sarcopenia
- Temporomandibular Muscle/Joint Disorder (TMJD)
- Muscular Dystrophy
- Hodgkin's Disease
- Paget's Disease
Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRCs)
Overview
The Muscular Dystrophy Community Assistance, Research, and Education Amendments (MD-CARE Act) of 2001 (Public Law 107-84) aimed to expand and intensify research on muscular dystrophies (MDs). The Act included language directing NIH to establish centers of excellence for research on these diseases. The MDSRC program (formerly the Muscular Dystrophy Cooperative Research Centers program) was later named in honor of Senator Paul D.
Magnetic Resonance Imaging and Spectroscopy Section
Richard Spencer , Ph.D., M.D., Chief
RNA Regulation Section
Myriam Gorospe , Ph.D., Chief
Brain Aging and Behavior Section
The overall goal of the Brain Aging and Behavior Section (BABS) is to improve cognitive outcomes with aging.
Clinical & Translational Neuroscience Section
Although rapid strides have been made in understanding the basic biology of Alzheimer's disease (AD), this knowledge has not been translated into earlier diagnosis and/or effective treatments for patients. The overarching goal of research in the Clinical and Translational Neuroscience Section (CTNS) is to comprehensively study the biologic basis of AD pathogenesis in humans.
Sergey Leikin Lab: Section on Physical Biochemistry
Welcome to Section on Physical Biochemistry @ NICHD.NIH
Our mission is to develop methods for diagnostics, monitoring and treatment of diseases based on better understanding their molecular mechanisms. We focus on the following studies:
Catherine Gordon Lab: Adolescent Bone & Body Composition Laboratory
A major focus of our research is identifying the factors during adolescence that may influence skeletal health during the adult years. We study how physical and emotional health are affected in adolescents and young women with Premature Ovarian Insufficiency (POI) by examining both the clinical presentation and underlying causes—including POI that can develop in childhood cancer survivors, and ovarian dysfunction of autoimmune, genetic or idiopathic (unknown) origin.